News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
24,073 Results
Type
Article (1017)
Company Profile (2)
Press Release (23054)
Section
Business (12773)
Career Advice (64)
Deals (1589)
Drug Development (2176)
Employer Resources (1)
FDA (360)
Job Trends (611)
News (16168)
Policy (632)
Tag
Academia (16)
Alliances (778)
ALS (12)
Alzheimer's disease (11)
Antibody-drug conjugate (ADC) (1)
Approvals (372)
Artificial intelligence (4)
Autoimmune disease (1)
Bankruptcy (4)
Best Places to Work (510)
Biotechnology (2)
Bladder cancer (5)
Brain cancer (1)
Breast cancer (5)
Cancer (90)
Cardiovascular disease (5)
Career advice (58)
CAR-T (3)
Cell therapy (12)
Clinical research (1917)
Collaboration (26)
Compensation (9)
Complete response letters (1)
COVID-19 (33)
CRISPR (3)
C-suite (3)
Data (116)
Depression (2)
Diabetes (8)
Diagnostics (226)
Digital health (1)
Drug discovery (1)
Drug pricing (1)
Duchenne muscular dystrophy (2)
Earnings (12094)
Employer resources (1)
Events (1833)
Executive appointments (3)
FDA (432)
Funding (11)
Gene editing (3)
Gene therapy (3)
GLP-1 (14)
Government (60)
Guidances (48)
Healthcare (596)
IgA nephropathy (2)
Immunology and inflammation (4)
Indications (3)
Infectious disease (35)
Inflammatory bowel disease (4)
Influenza (1)
Intellectual property (5)
Interviews (19)
IPO (1161)
Job creations (124)
Job search strategy (35)
Labor market (1)
Layoffs (6)
Legal (118)
Lung cancer (21)
Lymphoma (18)
Manufacturing (3)
MASH (4)
Medical device (569)
Medtech (569)
Mergers & acquisitions (441)
Metabolic disorders (22)
Multiple sclerosis (7)
NASH (1)
Neurodegenerative disease (2)
Neuropsychiatric disorders (3)
Neuroscience (37)
NextGen: Class of 2025 (108)
Non-profit (44)
Obesity (10)
Opinion (4)
Ovarian cancer (3)
Parkinson's disease (4)
Partnered (2)
Patents (10)
Patient recruitment (1)
People (562)
Phase I (434)
Phase II (699)
Phase III (853)
Pipeline (240)
Postmarket research (121)
Preclinical (209)
Prostate cancer (6)
Radiopharmaceuticals (5)
Rare diseases (3)
Real estate (100)
Recruiting (1)
Regulatory (506)
Reports (3)
Research institute (33)
Resumes & cover letters (11)
Schizophrenia (5)
Series A (1)
Sickle cell disease (2)
Special edition (1)
Spinal muscular atrophy (3)
Startups (39)
Supply chain (1)
Tariffs (2)
Vaccines (10)
Venture capital (1)
Weight loss (3)
Women's health (2)
Date
Last 7 days (5)
Last 30 days (48)
Last 365 days (1415)
2025 (679)
2024 (1683)
2023 (1862)
2022 (2023)
2021 (1981)
2020 (1731)
2019 (1125)
2018 (917)
2017 (701)
2016 (410)
2015 (711)
2014 (462)
2013 (265)
2012 (335)
2011 (417)
2010 (409)
Location
Africa (15)
Alabama (1)
Arizona (6)
Asia (1320)
Australia (161)
California (299)
Canada (81)
China (9)
Colorado (23)
Connecticut (7)
Delaware (13)
Europe (2632)
Florida (55)
Georgia (14)
Idaho (4)
Illinois (25)
Indiana (22)
Japan (3)
Kansas (4)
Kentucky (1)
Louisiana (5)
Maine (7)
Maryland (42)
Massachusetts (203)
Michigan (16)
Minnesota (23)
Mississippi (1)
Missouri (2)
Montana (1)
Nevada (4)
New Hampshire (4)
New Jersey (105)
New York (72)
North Carolina (36)
Northern California (153)
Ohio (11)
Pennsylvania (95)
South America (36)
Southern California (109)
Tennessee (5)
Texas (32)
United States (1167)
Utah (16)
Virginia (4)
Washington State (35)
West Virginia (1)
Wisconsin (2)
24,073 Results for "119".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
argenx Advances Clinical Development of ARGX-119 in Congenital Myasthenic Syndromes
June 30, 2025
·
6 min read
Press Releases
Proenkephalin A 119-159 (penKid) Leads the Way in Predicting Graft Outcomes for Kidney Transplant Recipients
July 1, 2025
·
3 min read
Press Releases
Generic Sterile Injectable Market Size to Reach USD 119.65 Bn by 2034 High Demand for Low-cost Treatments and Chronic Disease Prevalence
July 7, 2025
·
1 min read
Pharm Country
Aprea Therapeutics Announces that Safety Review Committee (SRC) Endorses Dosing of Patients with ATRN-119 at 800 mg Once Daily in Ongoing ABOYA-119 Clinical Trial
Aprea Therapeutics, Inc. today announced that the Safety Review Committee (SRC) overseeing the ongoing ABOYA-119 clinical trial has determined that dosing of patients with ATRN-119 at 800 mg once daily (Cohort 6) can commence and that Cohort 6 is open for enrollment.
May 28, 2024
·
7 min read
Press Releases
RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2025 REVENUE +11.9%, EBITDA(1) +10.7%, ADJUSTED NET INCOME(2) +7.2%
May 8, 2025
·
19 min read
Press Releases
Aprea Therapeutics Announces Twice Daily (BID) Dosing of Patients in ABOYA-119 Clinical Trial of ATRN-119 to Potentially Optimize Clinical Outcomes and Strengthen Clinical Path Forward
December 11, 2024
·
7 min read
Policy
Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant
Vivani Medical, Inc. announced the U.S. Food and Drug Administration has cleared the Investigational New Drug Application and lifted the clinical hold on NPM-119 to allow initiation of LIBERATE-1™, a Phase 1 clinical trial to assess the safety, tolerability and pharmacokinetics of NPM-119, the Company’s miniature, six-month GLP-1 implant in development for the treatment of type 2 diabetes.
June 13, 2024
·
7 min read
Biotech Beach
Rakuten Medical Closes $119 Million Series E Financing to Further Develop its Alluminox™ Platform
Rakuten Medical, Inc. announced the completion of a $119 million Series E preferred stock financing, including $45 million in new capital and the conversion of $74 million of convertible promissory notes with accrued interest.
March 6, 2024
·
7 min read
Biotech Bay
Leopard Imaging to Launch World’s First RGB-IR High Resolution Stereo Camera Eagle 2 LI-VB1940-GM2A-119H at Embedded Vision Summit 2024
Leopard Imaging Inc. (Leopard Imaging), a global leader in intelligent embedded camera design and manufacturing, is to launch stereo camera EAGLE 2 LI-VB1940-GM2A-119H at Embedded Vision Summit 2024.
May 21, 2024
·
3 min read
Fermion’s TYK2 JH2 Inhibitor FZ007-119 Granted IND Approval by China NMPA
Guangzhou Fermion Technology Co., Ltd. (Fermion) is pleased to announce the approval of the Investigational New Drug (IND) for its TYK2 JH2 inhibitor, FZ007-119, by the China National Medical Products Administration (NMPA).
February 5, 2024
·
2 min read
1 of 2,408
Next